Japan Researchers Aim For 2015 U.S. Trials Of iPS-Based Blood Platelets
This article was originally published in PharmAsia News
Executive Summary
Japanese researchers reportedly plan to seek permission to hold U.S. clinical trials for induced pluripotent stem cells to create platelets for a blood-clotting agent.